Fundraising FoxBiotech Startups
11,114 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
Oncotelic is a biopharmaceutical company developing oncology therapeutics, including immuno-oncology and nanomedicine approaches, and applying AI technology to drug development. It focuses on cancer treatments and other therapeutic areas.
0 investors
0 investors
ONCOtracker is an incubator-stage biotech company developing approaches for monitoring and treating patients with multiple myeloma, other B-cell malignancies, and related disorders. It is part of a family of oncology-focused companies associated with the Berenson Cancer Center in the United States.
0 investors
0 investors
0 investors
0 investors
OneOme is a precision medicine company that provides pharmacogenomics testing and analytics to healthcare providers, helping them optimize medication selection based on patients' genetic profiles. Co-founded by Mayo Clinic, the company serves healthcare teams and institutions globally seeking to improve patient outcomes and reduce costs through personalized medication decisions.
0 investors
OnKologic (Enable Life Sciences) develops Enable-NK cell culture media and a 10x concentrated supplement for expanding Natural Killer (NK) cells, used by NK cell research groups and in immuno-oncology cell therapy development. The products aim to improve NK cell performance metrics such as cytotoxicity, transduction efficiency, and cryopreservation for cancer research applications.
0 investors
OpenBench runs AI-enabled structure-based virtual screening to identify small molecule hit series for biotech drug discovery programs, screening large compound libraries and charging only for hits that meet a client-defined profile. It works with clients' own assays and CROs, offering a success-driven model where collaborators purchase resulting IP outright.
0 investors
Ophirex is a biotech company developing varespladib, an investigational oral capsule intended to treat snakebite envenomation by inactivating a key venom toxin found in most snake species. The drug is designed as a portable, field-administered rescue treatment to bridge the gap before hospital antivenom.
0 investors
0 investors
0 investors
Optimvia engineers proteins to create new therapeutic products, focusing on designing enzymes and enzyme systems for biosynthetic manufacturing of critical medicines like heparin. The company uses its proprietary ADEPT Platform to computationally design novel proteins for pharmaceutical applications.
0 investors
0 investors
0 investors
Opus KSD designs, manufactures, and distributes the SubQ-It! dermal fastener, a device for closing surgical incisions subcutaneously at the speed of a stapler but without staples. It is aimed at surgeons and operating room staff as an alternative to metal staples and sutures.
0 investors
0 investors
Oragenics develops treatments for concussion and traumatic brain injury, focusing on clinical development of therapeutic candidates. The company combines neuroscience expertise with healthcare operational leadership to advance solutions for brain injury treatment.
0 investors
Orbis Bio develops and manufactures specialized oral-dose and injectable drug delivery systems, operating global cGMP-compliant manufacturing sites. It also provides in-house regulatory affairs support to help clients move products from molecule to market.
0 investors
Orcosa is a clinical-stage life-sciences company developing the Rapid Infusion Technology (RITe) platform, orally disintegrating tablets designed to improve drug absorption through the cheek tissue without water. The company controls formulation, development, and manufacturing in-house and is advancing a proprietary cannabinoid composition for the management of pain and inflammation.
0 investors
0 investors
0 investors